4.4 Review

Olfactory Dysfunction: Common in Later Life and Early Warning of Neurodegenerative Disease

期刊

DEUTSCHES ARZTEBLATT INTERNATIONAL
卷 110, 期 1-2, 页码 1-U11

出版社

DEUTSCHER AERZTE-VERLAG GMBH
DOI: 10.3238/arztebl.2013.0001

关键词

-

资金

  1. Teva
  2. Takasago
  3. Unilever
  4. Fragrance Resources
  5. Primavera
  6. Bionorica
  7. Givaudan
  8. Burghart
  9. CIN Pharma
  10. Cephalon Pharma
  11. Merck Serono

向作者/读者索取更多资源

Background: Disturbances of smell and taste are common. About 5% of the general population have anosmia (absence of the sense of smell). Olfactory dysfunction can markedly impair the quality of life. Methods: Review of pertinent literature retrieved by a selective search. Results: In recent years, simple and reliable tests of the sense of smell have been introduced in otorhinolaryngology. Olfactory testing has become a new focus of attention in neurology as well, mainly because many patients with neurodegenerative diseases-including the majority of those with Parkinson's or Alzheimer's disease-have olfactory loss early on in the course of their disorder. Olfactory dysfunction is thus regarded as an early sign of neuro degenerative disease that may allow a tentative diagnosis to be made years before the motor or cognitive disturbances become evident. As for the treatment of olfactory loss, anti-inflammatory drugs and surgery can help in some cases, and olfactory training can lead to significant improvement of post-viral olfactory deficits. Conclusion: Olfactory dysfunction is common and becomes more common with advancing age. It is increasingly receiving attention as an important sign for the early diagnosis and the differential diagnosis of neurodegenerative disorders.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据